Pfizer (NYSE:PFE) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.32) by 46.88 percent. This is a 109.55 percent decrease over earnings of $1.78 per share from the same period last year. The company reported quarterly sales of $13.23 billion which beat the analyst consensus estimate of $12.72 billion by 4.03 percent. This is a 41.55 percent decrease over sales of $22.64 billion the same period last year.